Oncology

Diagnostics Genetics and epigenetics

11/10/2022 | Sponsored by QIAGEN | 6 min read

The need for molecular testing in NSCLC patients is growing – and QIAGEN can help you meet it

Diagnostics Omics

11/04/2022 | George Francis Lee

By uniting three medical disciplines, can we predict the effectiveness of non-small cell lung cancer treatment?

Subspecialties Oncology

11/03/2022 | Georgia Hulme | 2 min read

Investigating ethnic disparities in esophageal adenocarcinoma and prostate cancer

Subspecialties Oncology

10/31/2022 | George Francis Lee | 2 min read

How advances in our understanding of intratumor heterogeneity (ITH) may lay a path for new clinical applications

Diagnostics Liquid biopsy

10/27/2022 | George Francis Lee

Can a “plasma-first” approach to biopsy result in better testing for lung cancer?

Inside the Lab Bioinformatics

10/25/2022 | Ofer Sharon | 5 min read

Overcoming lung cancer treatment resistance requires predictive biomarkers that take into account patient variability

Diagnostics Biochemistry and molecular biology

10/12/2022 | George Francis Lee | 3 min read

The latest research news and views from the molecular pathology landscape

Inside the Lab Digital and computational pathology

10/03/2022 | Dean Bitan | 4 min read

In an aging world with cancer cases increasing, it’s time for technology

Diagnostics Biochemistry and molecular biology

09/30/2022 | Jeremiah McDole | 4 min read

Minimal residual disease testing could help more patients beat cancer – but first, we need tests that are precise, sensitive, and accurate enough

Inside the Lab Precision medicine

09/29/2022 | Yvonne Wallis, James Beasley | 6 min read

Size isn’t everything when it comes to next-generation sequencing. For one NHS consortium, using multiple panels is changing the game